Summary
Despite established links between the infant gut microbiome and health, how complementary feeding shapes colonization remains unclear. Using FoodSeq, a DNA-based dietary assessment technique, we surveyed food intake across 729 children (0-3 y) from North and Central America, Africa, and Asia. We detected 199 unique plant food sequences, with only eight staples shared across all countries. Despite this global variation, early-life diets followed a common trajectory: weaning stage emerged as the dominant dietary signature across populations. Crucially, dietary diversity did not correlate with gut microbial diversity. Instead, dietary diversity and weaning stage specifically predicted the abundance of adult-associated bacteria. Our findings support a two-stage maturation model: an initial milk-dominated phase, followed by a diet-responsive phase that yields adult-like communities. Monitoring and promoting plant dietary diversity may thus support timely microbiome maturation worldwide.
Competing Interest Statement
Dr. Wayne Shreffler reports personal consultant fees from ALK, Allerfund, Allergy Therapeutics, FARE, Milk Care Co. Mabylon, Novartis, Paraxel, Phylaxis and Third Rock Ventures; Clinical trial agreements with Aravax, DBV, Genentech, Moderna, Novartis, and Regeneron.
Funding Statement
This study was funded by the National Institutes of Health (NIH 5R01DK116187; NIH 5R01DK128611); the Gerber Foundation; the Chan Zuckerberg Initiative; the Burroughs Welcome Fund and Springer Nature
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Duke Health Institutional Review Board of Duke University waived ethical approval for this work under an exemption in the protocol Pro00100567
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The author list of this manuscript was revised; Figure 4 and Figure S2 were revised; Supplemental figures 5 and 6, displaying alternate model results, were added; Acknowledgements section was expanded; The manuscript also underwent overall formatting and stylistic revisions, as well as corrections in areas where the text did not match the figures.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
